CQC have released their 2018 review of controlled drugs, reporting on:

• the increase in opioid prescribing across the UK
• measures put in place following the Gosport Independent Panel report
• our continuing concerns regarding lower schedule controlled drugs
• the introduction of legislation for cannabis based medicinal products.

The report covers controlled drug accountable officers and their unaccounted-for losses of controlled drugs, by NHS England area. We also give examples of issues raised and followed up through the local area networks.

The full report can be accessed here